Publication:
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.

dc.contributor.authorParra, Diego
dc.contributor.authorPeña-Monje, Alejandro
dc.contributor.authorCoronado-Álvarez, Nieves María
dc.contributor.authorHernández-Quero, José
dc.contributor.authorParra-Ruiz, Jorge
dc.contributor.authoraffiliation[Parra,D; Coronado-Álvarez,NM; Hernández-Quero,J; Parra-Ruiz,J] Laboratorio de Investigación Antimicrobiana, Hospital Universitario San Cecilio. Instituto de Investigación Biosanitaria de Granada, Granada, Spain. [Peña-Monje,A] Servicio de Microbiología, Hospital Universitario San Cecilio, Granada, Spain. [Hernández-Quero,J; Parra-Ruiz,J] Servicio de Enfermedades Infecciosas, Hospital Universitario San Cecilio. Instituto de Investigación Biosanitaria de Granada, Granada, Spain.es
dc.date.accessioned2016-10-21T07:40:08Z
dc.date.available2016-10-21T07:40:08Z
dc.date.issued2015-10-30
dc.descriptionJournal Article;es
dc.description.abstractBACKGROUND Despite widespread use, optimum choice of antimicrobial agents, concentrations, combinations and exposure times have not been determined for antibiotic lock technique (ALT). Our objective was to evaluate the efficacy of different antibiotic combinations using an in vitro model of catheter-related infection. Daptomycin (DAP) 5 mg/mL, teicoplanin (TEC) 5 mg/mL, both alone and combined with gentamicin (GM) 2.5 mg/mL, clarythromycin (CLA) 5 mg/mL or ethanol 35 % were evaluated against four clinical strains of methicillin resistant coagulase negative staphylococci. Lock solutions were renewed every 24 h. RESULTS After 72 h catheters were reincubated with culture media to investigate bacterial regrowth. All antibiotic combinations resulted in significant reductions (p < 0.05) of Log(10) cfu/mL at 72 h for both organisms compared with controls. DAP resulted in significant reductions of Log(10) for all organism versus TEC (p = 0.001). Only DAP reached the limit of detection at 72 h, however did not prevent regrowth after 24 h of ALT removal. DAP + Ethanol and TEC + ethanol eradicated biofilm at 72 h, but only DAP + ethanol (against all strains) and DAP + CLA (against two strains) prevented regrowth at 24 h after ALT removal. CONCLUSIONS Based on these data, ALT with DAP + ethanol and DAP + CLA should be explored in clinical trials.es
dc.description.versionYeses
dc.identifier.citationParra D, Peña-Monje A, Coronado-Álvarez NM, Hernández-Quero J, Parra-Ruiz J. In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions. BMC Microbiol. 2015.; 15:245es
dc.identifier.doi10.1186/s12866-015-0585-3
dc.identifier.essn1471-2180
dc.identifier.pmcPMC4628264
dc.identifier.pmid26518881
dc.identifier.urihttp://hdl.handle.net/10668/2479
dc.journal.titleBMC Microbiology
dc.language.isoen
dc.publisherBioMed Centrales
dc.relation.publisherversionhttp://bmcmicrobiol.biomedcentral.com/articles/10.1186/s12866-015-0585-3es
dc.rights.accessRightsopen access
dc.subjectCentral line associated bloodstream infectionses
dc.subjectAntibiotic lock therapyes
dc.subjectBiofilmes
dc.subjectAntibacterianoses
dc.subjectCatétereses
dc.subjectClaritromicinaes
dc.subjectDaptomicinaes
dc.subjectQuimioterapia combinadaes
dc.subjectEtanoles
dc.subjectBiofilmeses
dc.subjectGentamicinases
dc.subjectHumanoses
dc.subjectTécnicas In vitroes
dc.subjectResistencia a la meticilinaes
dc.subjectPruebas de sensibilidad microbianaes
dc.subjectTeicoplaninaes
dc.subjectVancomicinaes
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Biofilmses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Equipment and Supplies::Catheterses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Lactones::Macrolides::Erythromycin::Clarithromycines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Peptides, Cyclic::Daptomycines
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combinationes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Alcohols::Ethanoles
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicinses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Drug Resistance, Microbial::Drug Resistance, Bacterial::beta-Lactam Resistance::Penicillin Resistance::Methicillin Resistancees
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Microbial Sensitivity Testses
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Rods::Staphylococcaceae::Staphylococcus::Staphylococcus epidermidises
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Teicoplanines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Vancomycines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agentses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::In Vitro Techniqueses
dc.titleIn vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Parra_InVitroEfficacy.pdf
Size:
680.09 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado